Skip to content
Search

Latest Stories

UK economy grinds to halt in August

Britain's Brexit-facing economy ground to a shuddering halt in August, hit by weaker hotel and restaurant activity, official data showed Wednesday (10).

Six months before Britain is due to leave the European Union, gross domestic product (GDP) registered zero growth, the Office for National Statistics said in a statement.


That followed an upwardly-revised 0.4-percent expansion in July, which was boosted by sunny weather and the World Cup football tournament.

The ONS added that the 2018 summer heatwave provided a welcome lift to the economy after it had suffered under unusually cold weather earlier in the year.

The August GDP print however undershot analysts' consensus forecasts for anaemic growth of 0.1 percent.

Meanwhile, the economy grew 0.7 percent in the three months to August compared with the previous three months. That outpaced market expectations of 0.6 percent.

"The economy continued to rebound strongly after a weak spring, with retail, food and drink production and housebuilding all performing particularly well during the hot summer months," said Rob Kent-Smith, ONS head of GDP.

"However, long-term growth continues to lag behind its historical trend."

Howard Archer, chief economic advisor to the EY ITEM Club, forecast that growth would rebound in the third quarter of this year, or three months to September.

However, he cautioned that Brexit uncertainty would likely spark another slowdown towards the end of the year.

"We think there is a very real risk that growth will slow markedly in the fourth quarter due to appreciable Brexit and political uncertainties weighing down on business investment and also limiting client willingness to place major contracts," he noted.

Britain will depart from the European Union at the end of March 2019.

More For You

Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less
Grant Thornton's Anuj Chande urges UK firms to tap booming India

Anuj Chande

Grant Thornton's Anuj Chande urges UK firms to tap booming India

INDIAN companies are well placed to support the UK’s economic growth, Eastern Eye has been told by Anuj Chande, partner and head of the South Asia Business Group at Grant Thornton.

He was speaking after the publication of Grant Thornton’s India Meets Britain Tracker 2025: The latest trends in Indian investment in the UK, which was released last week. While companies in India need little encouragement to enter the UK market, the reverse is not true.

Keep ReadingShow less